Kailera Therapeutics, Inc. KLRA · SEC Filings

website

145

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapi...

Price13.7

Market Cap1.78 B

Float89.39 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 26, 2026

News

TYPE

HEADLINE

FILED AT

8-K

Kailera Therapeutics Reports Q3 2026 Financial Results and Pipeline Progress

Nov 4, 2026

8-K

Kailera Therapeutics Reports Second Quarter 2026 Financial Results and Pipeline Progress

Aug 12, 2026

8-K

Kailera Therapeutics Reports Q1 2026 Financial Results and Clinical Pipeline Progress

May 26, 2026

8-K

Kailera Therapeutics, Inc. Completes Initial Public Offering and Amends Corporate Governance Documents

Apr 20, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

IPO | Offering amount: $625,000,000 | Shares: 39,062,500 | Price: $16.000 | Bank: J.P. Morgan

Apr 17, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 17, 2026

S-1MEF

OFFERING - Other

Apr 16, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Apr 14, 2026

S-1/A

OFFERING - IPO | Bank: J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, Evercore ISI

Apr 13, 2026

S-1

OFFERING - IPO | Bank: J.P. Morgan; Jefferies; Leerink Partners; TD Cowen; Evercore ISI; William Blair

Mar 27, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Feb 11, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Nicholson Nur (Reporting)

Sep 9, 2026

Nicholson Nur (Reporting)

Sep 9, 2026

SCHEDULE 13G

CANADA PENSION PLAN INVESTMENT BOARD (Filed by)

Aug 14, 2026

SCHEDULE 13G

RTW INVESTMENTS, LP (Filed by)

Aug 14, 2026

SCHEDULE 13G

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Filed by)

Aug 5, 2026

Tregoning Kathleen (Reporting)

Jul 8, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 17, 2026